November 21, 2025 · Form 4 insider transaction
Watanabe Todd sold 1,055 shares of Arcutis Biotherapeutics, Inc. at $30.00 per share, a transaction worth $31.6K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 3 days after the transaction.
The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on June 3, 2025, by the Reporting Person, with a plan end date of September 30, 2026.